Our Sectors
We are experts at what we do
01
Our People
A dedicated team of executive search experts, delivering for you
The Compass Carter Osborne team are healthcare and life science experts. As a trusted advisor we bring decades of search experience and an unparalleled track record of delivery across our dedicated sectors for our investor clients – relied upon time and again to build outstanding leadership teams.
Familiar faces at key industry events, our expertise extends beyond the mere placing of people with our consultants bringing together sector leaders to address key challenges, working in partnership to produce tangible solutions.
02
Expertise
Unearthing rare talent, that drive successful exits
Responsive, adaptable, and emotionally intelligent, Compass Carter Osborne avoid the one-size-fits-all approach to ensure our clients achieve their desired outcome by presenting a broad range of intuitive, tailored solutions, based on specific needs.
03
Our Approach
Tailoring our offering,
to provide a bespoke service
Results driven, not process led, CCO avoid the conformity of a rigid process. Never assumptive, we listen and adopt an agreed approach which most closely delivers to a clients specific needs. Understanding the uniqueness of each role, our people tailor a search to bespoke requirements to ensure solutions that delivers the best possible results first time, every time.
A trusted advisor to the investment community
providing leaders advancing the healthcare and life sciences sectors
What our clients say
“Compass Carter Osborne really delivered for us in our search for a new CEO for Outcomes First Group. It was a vitally important assignment given that we were recruiting a successor for a long standing and highly successful CEO in a sector-leading business. Compass Carter Osborne went above and beyond in developing a deep understanding of the business and our requirements, and in only presenting candidates that closely met these. They think very creatively and their focus was very sharp; they particularly understood the culture of the business. The search was speedy and well organised, with a very high standard of verbal and written feedback. They have a granular knowledge of the sector and because of the way in which they work, we were fully involved throughout and achieved a great result. A really excellent search – thank you.”
Outcomes First Group – Chair
“Compass Carter Osborne started from the very beginning with a detailed, professional explanation of the available position. They spent time to present the great opportunity and chance to accelerate my career but at the same time, the challenge, and the strong expectation from their client.”
Hengrui Therapeutics – VP, Head Biological Drug Discovery
“Compass Carter Osborne delivered on a key appointment for the PFA and the wider football industry. It was a complex brief involving creating an entirely new position. The role was vitally important, with the successful candidate taking on a sensitive and multifaceted responsibility across CTE, concussion and brain health in professional football. CCO led a comprehensive and exhaustive process, developing a deep understanding of the union’s requirements and using his expert knowledge to help scope and evolve the brief throughout the search. The entire process was professional, efficient and well organised, with consistent communication and feedback at every stage.”
The Professional Footballers Association (PFA) – Chief Executive Officer
“I have been so impressed by Luke’s integrity, clear purpose and drive to achieve for his clients. Luke has worked with Priory on a number of things but more recently to source two independent Non Executive Directors and a Director of Talent Acquisition. He has kept us informed, fielded some great candidates and follows up at each stage, even when they have started. I would really recommend him if you are searching for high calibre individuals.”
Priory Group – Chief Executive Officer
“I recently had the pleasure of being appointed to an independent healthcare provider as a NED after being put forward for the role by Luke. Throughout the whole recruitment process I was treated with respect and felt valued. I was particularly impressed with the follow up support after the decision to appoint me, which I have never experienced from other search companies. Luke continued to check in with me to ensure my onboarding went smoothly and that I had settled into the role. Overall, a highly professional and comprehensive approach delivered personally by Luke.”
Priory – Independent Non-Executive Director
“Luke was absolutely brilliant along the journey. He acted as a real partner and was able to answer to all my questions in order to get comfortable with the decision of making the change. His expertise and knowledge of the sector really came out along the process. Most importantly, he was always available when I needed him to be, which is something I valued a lot. In summary, I couldn’t recommend him and Compass Carter Osborne enough.”
AniCura – Group Chief Operating Officer
“We worked with Compass Carter Osborne in the search for our Chief Financial Officer and from the start it was clear they were a good choice of partner. A focus on understanding our needs as a business, and mine personally as a CEO were front of mind for Paul and Kieran. They took the time to listen, understand and not only focus on the functional aspects of the role – but critically, the team fit and culture we are building.
Process, structure and follow-through were like clockwork, and the quality of candidates were of a consistently high-level. I would highly recommend Compass Carter Osborne.”
Renaiss Health – Chief Executive Officer
“I’ve known Tarquin for over 15 years, during which time he has delivered a number of executive assignments at senior level, including COO/executive team and senior management roles in scientific/professional disciplines (his network in the biotech/life-sciences sector is second-to-none!). He works hard to truly understand both the candidate brief and the culture of the company, sets realistic expectations and retains regular contact as an assignment progresses, always providing thorough updates and pragmatic advice. He has the highest levels of professionalism and integrity – he really is a pleasure to work with.”
One Nucleus – Director
“Jamie did a great job – he really took the time to understand our business, our needs and what we were looking for. We knew our brief was specific, yet Jamie met all our expectations with the search. He maintained a high standard of communication and meticulous attention to detail throughout the process. I would recommend Jamie and the Compass Carter Osborne team without hesitation.”
Melrose Education – Chair & CEO
“Our recent work with Compass Carter Osborne was exceptional. The search was perfectly organised, response times were swift, and due to the consultant market knowledge and network, we quickly found our ideal candidate.”
Schoen Clinic – Member of Group Executive
Healthcare news, data and analysis
Via Investors in Healthcare
Ireland: Huron acquires RelateCare from MML to strengthen patient access and care coordination capabilities
Nasdaq‑listed Huron, the US‑based global professional services firm, has acquired RelateCare, an Ireland‑headquartered provider of AI‑enabled clinical and patient access solutions, from MML Ireland. The deal enhances Huron’s ability to […]
Nasdaq‑listed Huron, the US‑based global professional services firm, has acquired RelateCare, an Ireland‑headquartered provider of AI‑enabled clinical and patient access solutions, from MML Ireland. The deal enhances Huron’s ability to […]
Ireland: Huron acquires RelateCare from MML to strengthen patient access and care coordination capabilities
June 4, 2026
Life Sciences
M&A
Medtech – Healthcare IT
News
Conor O’Byrne
UK: Wouter Van den Brande joins Song Capital as managing operating partner
Wouter Van den Brande has joined Song Capital, the UK-based European investment grade private credit firm founded, as managing operating partner. Van den Brande is a senior healthcare operator and […]
Wouter Van den Brande has joined Song Capital, the UK-based European investment grade private credit firm founded, as managing operating partner. Van den Brande is a senior healthcare operator and […]
UK: Wouter Van den Brande joins Song Capital as managing operating partner
June 4, 2026
Care Homes
Debt
Healthcare
Hospitals and Clinics
News
Indonesia: Fullerton Health completes acquisition of AdMedika from TelkomMetra
Singapore-based integrated healthcare group, Fullerton Health, has completed its acquisition of Administrasi Medika (AdMedika), including its subsidiary TelkoMedika, from Multimedia Nusantara (TelkomMetra), a subsidiary of Telkom Indonesia (Persero). The acquisition strengthens Fullerton Health’s healthcare capabilities in Indonesia by adding a […]
Singapore-based integrated healthcare group, Fullerton Health, has completed its acquisition of Administrasi Medika (AdMedika), including its subsidiary TelkoMedika, from Multimedia Nusantara (TelkomMetra), a subsidiary of Telkom Indonesia (Persero). The acquisition strengthens Fullerton Health’s healthcare capabilities in Indonesia by adding a […]
Indonesia: Fullerton Health completes acquisition of AdMedika from TelkomMetra
June 3, 2026
Life Sciences
M&A
Medtech – Healthcare IT
News
AdMedika
US: Resmed expands clinical sleep health portfolio with completion of Noctrix Health acquisition
NYSE and ASX-listed Resmed, a US-based sleep health technology company, has completed its acquisition of Noctrix Health, a US-based medical device company developing clinically validated wearable therapeutics for chronic neurological […]
NYSE and ASX-listed Resmed, a US-based sleep health technology company, has completed its acquisition of Noctrix Health, a US-based medical device company developing clinically validated wearable therapeutics for chronic neurological […]
US: Resmed expands clinical sleep health portfolio with completion of Noctrix Health acquisition
June 3, 2026
Life Sciences
M&A
Medtech – Medical Devices and Implants
News
Angelini Ventures
UK: Bridgepoint agrees acquisition of Obagi Medical from Waldencast for up to US$460m
LSEG-listed Bridgepoint, a leading mid-market investor, has agreed to acquire Obagi Medical, the dermatological skincare and aesthetics business of Nasdaq-listed Waldencast, in a transaction valued at up to US$460m. “Obagi […]
LSEG-listed Bridgepoint, a leading mid-market investor, has agreed to acquire Obagi Medical, the dermatological skincare and aesthetics business of Nasdaq-listed Waldencast, in a transaction valued at up to US$460m. “Obagi […]
UK: Bridgepoint agrees acquisition of Obagi Medical from Waldencast for up to US$460m
June 3, 2026
Cosmetic & Aesthetics
Healthcare
M&A
News
Bridgepoint
Norway: Rubicon Healthcare Partners appoints Claire Knoph as COO/CFO
Rubicon Healthcare Partners (RHP), a growth equity asset manager primarily focused on Nordic life science companies, has appointed Claire Knoph as COO and CFO. Her appointment brings dedicated operational and […]
Rubicon Healthcare Partners (RHP), a growth equity asset manager primarily focused on Nordic life science companies, has appointed Claire Knoph as COO and CFO. Her appointment brings dedicated operational and […]
Norway: Rubicon Healthcare Partners appoints Claire Knoph as COO/CFO
June 3, 2026
Life Sciences
News
People
Pharma
Services – CRO/CMO/CDMO
UK: Star Capital Partnership acquires Glenholme’s specialist care division
Star Capital Partnership, a UK-based private equity firm focused on asset-based businesses in Western Europe, has acquired the Glenholme Specialist Care Division (Glenholme SC) from Glenholme Healthcare Group, a UK-based […]
Star Capital Partnership, a UK-based private equity firm focused on asset-based businesses in Western Europe, has acquired the Glenholme Specialist Care Division (Glenholme SC) from Glenholme Healthcare Group, a UK-based […]
UK: Star Capital Partnership acquires Glenholme’s specialist care division
June 3, 2026
Buy Out
Care Homes
Complex Behavioural Care
M&A
M&A Deals
UK: Take part in the Christie & Co UK Care Home Sentiment survey
Christie & Co has launched a new sentiment survey to capture the perspectives, experiences, and plans of care home operators across the UK. It’s an opportunity to contribute directly to […]
Christie & Co has launched a new sentiment survey to capture the perspectives, experiences, and plans of care home operators across the UK. It’s an opportunity to contribute directly to […]
UK: Take part in the Christie & Co UK Care Home Sentiment survey
June 2, 2026
Care Homes
News
Social Care
Christie & Co
UK
Belgium: UCB completes acquisition of Neurona Therapeutics
Euronext-listed UCB, a Belgium-based global biopharmaceutical company, has acquired Neurona Therapeutics, a US-based clinical-stage biotherapeutics company developing regenerative cell therapies, for a total transaction valued of up to US$1.15bn consisting […]
Euronext-listed UCB, a Belgium-based global biopharmaceutical company, has acquired Neurona Therapeutics, a US-based clinical-stage biotherapeutics company developing regenerative cell therapies, for a total transaction valued of up to US$1.15bn consisting […]
Belgium: UCB completes acquisition of Neurona Therapeutics
June 2, 2026
M&A
Manufacturing – Specialty Pharma
News
Pharma
Belgium
Spain: Cooper Consumer Health acquires the Ferrer Consumer Healthcare business in Spain
Cooper Consumer Health, a France-based European consumer healthcare company, has acquired the Ferrer Consumer Healthcare business in Spain. Cooper Consumer Health’s Spanish business grew fivefold in 2024 through the acquisition […]
Cooper Consumer Health, a France-based European consumer healthcare company, has acquired the Ferrer Consumer Healthcare business in Spain. Cooper Consumer Health’s Spanish business grew fivefold in 2024 through the acquisition […]
Spain: Cooper Consumer Health acquires the Ferrer Consumer Healthcare business in Spain
June 2, 2026
Consumer Healthcare
Healthcare
M&A
News
Avista Capital
France: Servier acquires muscular dystrophy business of Edgewise Therapeutics for up to US$2.65bn
France-based Servier, an independent international pharmaceutical group governed by a foundation, is to acquire sevasemten and the muscular dystrophy business of Edgewise Therapeutics, a US-based muscle disease biopharmaceutical company, for up to US$2.65bn, consisting of an […]
France-based Servier, an independent international pharmaceutical group governed by a foundation, is to acquire sevasemten and the muscular dystrophy business of Edgewise Therapeutics, a US-based muscle disease biopharmaceutical company, for up to US$2.65bn, consisting of an […]
France: Servier acquires muscular dystrophy business of Edgewise Therapeutics for up to US$2.65bn
June 1, 2026
M&A
Manufacturing – Specialty Pharma
News
Pharma
Centerview Partners
US: Genstar-backed Signant Health acquires Ametris from Archimed
US-based Signant Health, an evidence generation company, has acquired Ametris (formerly ActiGraph), a global digital health solutions provider, from Archimed. Signant Health was formed in 2018 by the merger of CRF […]
US-based Signant Health, an evidence generation company, has acquired Ametris (formerly ActiGraph), a global digital health solutions provider, from Archimed. Signant Health was formed in 2018 by the merger of CRF […]
US: Genstar-backed Signant Health acquires Ametris from Archimed
June 1, 2026
Buy Out
Life Sciences
M&A
Medtech – Healthcare IT
News
UK: John Gillie appointed as CFO at Sciensus
John Gillie has been appointed CFO at Sciensus, a UK-based provider of complex clinical care at home. Gillie brings more than 34 years of experience in pharma services and life […]
John Gillie has been appointed CFO at Sciensus, a UK-based provider of complex clinical care at home. Gillie brings more than 34 years of experience in pharma services and life […]
UK: John Gillie appointed as CFO at Sciensus
June 1, 2026
Distribution
Healthcare
Homecare
News
People
Japan: Meiji Seika Pharma invests in GHIC’s Global Health Security Fund
Japan-headquartered Meiji Seika Pharma has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based non-profit organisation. Through […]
Japan-headquartered Meiji Seika Pharma has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based non-profit organisation. Through […]
Japan: Meiji Seika Pharma invests in GHIC’s Global Health Security Fund
June 1, 2026
Life Sciences
News
Pharma
Global Health Investment Corporation (GHIC)
Global Health Security Fund (GHSF)
US: Ampersand closes AMP-26 fund at US$1.5bn hard cap
US-based global healthcare and life sciences investor, Ampersand Capital Partners, has announced the closing of its latest fund, Ampersand 2026, with US$1.5bn in LP commitments. Ampersand’s oversubscribed 2026 fund – its […]
US-based global healthcare and life sciences investor, Ampersand Capital Partners, has announced the closing of its latest fund, Ampersand 2026, with US$1.5bn in LP commitments. Ampersand’s oversubscribed 2026 fund – its […]
US: Ampersand closes AMP-26 fund at US$1.5bn hard cap
June 1, 2026
Healthcare
Life Sciences
News
Pharma
Ampersand Capital Partners
Switzerland: CordenPharma expands global peptides platform in US and China
Switzerland-based global CDMO, CordenPharma, has agreed to acquire AmbioPharm, a US-headquartered peptide API CDMO, from Carlyle. The acquisition builds on CordenPharma’s global facility network of 11 sites in Europe and North […]
Switzerland-based global CDMO, CordenPharma, has agreed to acquire AmbioPharm, a US-headquartered peptide API CDMO, from Carlyle. The acquisition builds on CordenPharma’s global facility network of 11 sites in Europe and North […]
Switzerland: CordenPharma expands global peptides platform in US and China
June 1, 2026
Buy Out
M&A
News
Pharma
Services – CRO/CMO/CDMO
Switzerland: Siegfried places CHF200m four-year senior bonds
SIX-listed CDMO, Siegfried, has issued a CHF200m four-year bond paying a coupon of 1.35%. “This transaction further strengthens Siegfried’s financial position and maintains strategic flexibility for future growth initiatives,” said […]
SIX-listed CDMO, Siegfried, has issued a CHF200m four-year bond paying a coupon of 1.35%. “This transaction further strengthens Siegfried’s financial position and maintains strategic flexibility for future growth initiatives,” said […]
Switzerland: Siegfried places CHF200m four-year senior bonds
May 26, 2026
Debt
News
Pharma
Services – CRO/CMO/CDMO
Reto Suter
Germany: Fresenius to launch new €1bn share buyback programme in next few weeks
Fresenius Medical Care (FME), a global provider of products and services for individuals with renal diseases, intends to execute a €1bn share buyback programme to be executed in tranches over […]
Fresenius Medical Care (FME), a global provider of products and services for individuals with renal diseases, intends to execute a €1bn share buyback programme to be executed in tranches over […]
Germany: Fresenius to launch new €1bn share buyback programme in next few weeks
May 26, 2026
Digital Health/Healthtech
Healthcare
News
Public Equity
Fresenius Medical Care
Australia: Jardines to acquire I-MED from Permira for AUD3.4bn
London- and Singapore-listed Jardine Matheson, an Asia Pacific-focused investment company, has agreed the acquisition of I-MED Radiology Network, a global diagnostic imaging and teleradiology business based in Australia, from funds […]
London- and Singapore-listed Jardine Matheson, an Asia Pacific-focused investment company, has agreed the acquisition of I-MED Radiology Network, a global diagnostic imaging and teleradiology business based in Australia, from funds […]
Australia: Jardines to acquire I-MED from Permira for AUD3.4bn
May 26, 2026
Buy Out
Diagnostics
Healthcare
Life Sciences
M&A
Spain: HIG Capital to acquire Vitaly Group through portfolio company Avanta Salud in pursuit of international expansion
Avanta Salud Integral, a portfolio company of US-based global alternative investment firm HIG Capital, is to acquire Vitaly Group, one of the leading occupational health and safety (OHS) services providers […]
Avanta Salud Integral, a portfolio company of US-based global alternative investment firm HIG Capital, is to acquire Vitaly Group, one of the leading occupational health and safety (OHS) services providers […]
Spain: HIG Capital to acquire Vitaly Group through portfolio company Avanta Salud in pursuit of international expansion
May 26, 2026
Buy Out
Consumer Healthcare
Digital Health/Healthtech
Healthcare
M&A
Germany: Avista Healthcare Partners and Damier to acquire sanotact Group
Avista Healthcare Partners, a US-based healthcare-focused private equity firm, and Damier Group, the Belgium-based family office of Yvan Vindevogel, have signed a definitive agreement to acquire sanotact Group, a Germany-based […]
Avista Healthcare Partners, a US-based healthcare-focused private equity firm, and Damier Group, the Belgium-based family office of Yvan Vindevogel, have signed a definitive agreement to acquire sanotact Group, a Germany-based […]
Germany: Avista Healthcare Partners and Damier to acquire sanotact Group
May 25, 2026
Buy Out
Consumer Healthcare
Healthcare
M&A
News
France: Bregal Sagemount and Ardian invest in Ennov’s next phase of growth
Ennov, a France-based global provider of end-to-end regulatory, quality, and clinical software solutions for life sciences and healthcare companies, has received a strategic growth investment in support of its continued […]
Ennov, a France-based global provider of end-to-end regulatory, quality, and clinical software solutions for life sciences and healthcare companies, has received a strategic growth investment in support of its continued […]
France: Bregal Sagemount and Ardian invest in Ennov’s next phase of growth
May 25, 2026
Life Sciences
Medtech – Healthcare IT
News
Venture
Alexis Saada
Italy: CVC and GBL to top-up shareholding of Recordati in take-private bid
A consortium of funds led by CVC and GBL have entered into binding agreements for the launch of a voluntary cash tender offer for all outstanding ordinary shares of Euronext […]
A consortium of funds led by CVC and GBL have entered into binding agreements for the launch of a voluntary cash tender offer for all outstanding ordinary shares of Euronext […]
Italy: CVC and GBL to top-up shareholding of Recordati in take-private bid
May 22, 2026
M&A
Manufacturing – Generics
Manufacturing – Specialty Pharma
News
Pharma
Sweden: HealthCap invests in Neobiomics to support continued growth in neonatal care
Neobiomics, a Swedish life science company focused on improving outcomes for preterm infants through evidence-based nutritional products, has received an investment led by HealthCap, a specialist provider of life sciences […]
Neobiomics, a Swedish life science company focused on improving outcomes for preterm infants through evidence-based nutritional products, has received an investment led by HealthCap, a specialist provider of life sciences […]
Sweden: HealthCap invests in Neobiomics to support continued growth in neonatal care
May 22, 2026
Life Sciences
News
Venture
Emma Höglund
HealthCap
Belgium: Full-Life Technologies raises US$150m to advance clinical stage assets
Full-Life Technologies, a clinical stage radiotherapeutics company with operations in Belgium, Germany, and China, has raised US$150m led by Vivo Capital. Vivo was joined in the financing package, consisting of […]
Full-Life Technologies, a clinical stage radiotherapeutics company with operations in Belgium, Germany, and China, has raised US$150m led by Vivo Capital. Vivo was joined in the financing package, consisting of […]
Belgium: Full-Life Technologies raises US$150m to advance clinical stage assets
May 22, 2026
Life Sciences
Medtech – Diagnostics
News
Venture
Belgium
The latest insights from
Compass Carter Osborne
Insights from the Investors in Healthcare Real Assets Conference
Insights from the Investors in Healthcare Real Assets Conference
February 9, 2026
Healthcare
Insight
